2,2'-bipyridine-4,5'-dicarboxylic acid | 950758-45-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2,2'-bipyridine-4,5'-dicarboxylic acid
• 英文别名: 6-(4-carboxypyridin-2-yl)pyridine-3-carboxylic acid
• CAS: 950758-45-9
• 化学式: C₁₂H₈N₂O₄
• 分子量: 244.207
• InChiKey: HYDLFVISOOYNGJ-UHFFFAOYSA-N

物化性质

• 沸点：
  621.2±55.0 °C(Predicted)
• 密度：
  1.469±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  100
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  乙醇 、 2,2'-bipyridine-4,5'-dicarboxylic acid 在 氯化亚砜 作用下， 反应 24.0h， 以77%的产率得到diethyl 2,2'-bipyridine-4,5'-dicarboxylate
  参考文献：
  名称：

  INHIBITORS OF COLLAGEN PROLYL 4-HYDROXYLASE

  摘要：

  Biheteroaryl二羧酸酯和酯，以及它们的盐，可用作CP4H活性的调节剂，更具体地作为CP4H的抑制剂。化合物的结构式:及其盐，其中:X为S、O、NH或NR，其中R为具有1-3个碳原子的烷基基团；R1和R2独立地为—OR7，或—NHSO2R8，其中R7选自：氢、烷基、烯基、烷氧基烷基、—R′—CO—R″、—R′—CO—O—R″、—CO—R″、—R′—O—CO—R″、—R′—CO—NR″、—CO—NR″或—R′—O—CO—NR″，而R8选自氢、烷基、芳基、芳基烷基；R3、R4和R6独立地为氢、烷基、烷氧基、烯基、烯氧基、卤代烷基、卤代烯基、卤素、羟基、羟基烷基、羟基烯基、芳基、芳氧基、芳基烷基或芳基烷氧基；R5为氢、卤素、具有1-3个碳原子的烷基，或具有1-3个碳原子的烷氧基；—R′—为二价的直链或支链烷基，而—R″为烷基、烯基、芳基烷基或芳基。用于体内和体外抑制CP4H的方法。

  公开号：

  US20160280701A1
• 作为产物：
  描述：

  烟酸甲酯 在 palladium diacetate 、 potassium carbonate 、 间氯过氧苯甲酸 、 potassium hydroxide 、 tri tert-butylphosphoniumtetrafluoroborate 、 三氯化磷 作用下， 以 甲醇 、 二氯甲烷 、 氯仿 、 甲苯 为溶剂， 反应 42.0h， 生成 2,2'-bipyridine-4,5'-dicarboxylic acid
  参考文献：
  名称：

  INHIBITORS OF COLLAGEN PROLYL 4-HYDROXYLASE

  摘要：

  Biheteroaryl二羧酸酯和酯，以及它们的盐，可用作CP4H活性的调节剂，更具体地作为CP4H的抑制剂。化合物的结构式:及其盐，其中:X为S、O、NH或NR，其中R为具有1-3个碳原子的烷基基团；R1和R2独立地为—OR7，或—NHSO2R8，其中R7选自：氢、烷基、烯基、烷氧基烷基、—R′—CO—R″、—R′—CO—O—R″、—CO—R″、—R′—O—CO—R″、—R′—CO—NR″、—CO—NR″或—R′—O—CO—NR″，而R8选自氢、烷基、芳基、芳基烷基；R3、R4和R6独立地为氢、烷基、烷氧基、烯基、烯氧基、卤代烷基、卤代烯基、卤素、羟基、羟基烷基、羟基烯基、芳基、芳氧基、芳基烷基或芳基烷氧基；R5为氢、卤素、具有1-3个碳原子的烷基，或具有1-3个碳原子的烷氧基；—R′—为二价的直链或支链烷基，而—R″为烷基、烯基、芳基烷基或芳基。用于体内和体外抑制CP4H的方法。

  公开号：

  US20160280701A1

文献信息

• Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates
  作者：James D. Vasta、Ronald T. Raines

  DOI：10.1016/j.bmc.2015.05.003

  日期：2015.7

  Collagen is the most abundant protein in animals. A variety of indications are associated with the overproduction of collagen, including fibrotic diseases and cancer metastasis. The stability of collagen relies on the posttranslational modification of proline residues to form (2S,4R)-4-hydroxyproline. This modification is catalyzed by collagen prolyl 4-hydroxylases (CP4Hs), which are Fe(II)- and alpha-ketoglutarate (AKG)-dependent dioxygenases located in the lumen of the endoplasmic reticulum. Human CP4Hs are validated targets for treatment of both fibrotic diseases and metastatic breast cancer. Herein, we report on 2,2'-bipyridinedicarboxylates as inhibitors of a human CP4H. Although most 2,2'-bipyridinedicarboxylates are capable of inhibition via iron sequestration, the 4,5'-and 5,5'-dicarboxylates were found to be potent competitive inhibitors of CP4H, and the 5,5'-dicarboxylate was selective in its inhibitory activity. Our findings clarify a strategy for developing CP4H inhibitors of clinical utility. (C) 2015 Elsevier Ltd. All rights reserved.
• A simple and environmentally benign synthesis of polypyridine-polycarboxylic acids
  作者：Niamh R. Kelly、Sandrine Goetz、Chris S. Hawes、Paul E. Kruger

  DOI：10.1016/j.tetlet.2010.12.074

  日期：2011.3

  An oxidation method using dilute nitric acid solutions under solvothermal conditions has been developed to synthesise a series of polypyridine-polycarboxylic acids. It has been successfully applied to a range of methyl substituted polypyridines including symmetrical and asymmetrical 2,2'-bipyridines; 2,2':6',2 ''-terpyridines and; 2,2':6',2 '':6 '',2'''-tetra-pyridines and yields crystalline polypyridine-polycarboxylic acids in a single step. Simple product recovery through filtration yields a recyclable filtrate. More forcing conditions led to demethylation of the polypyridine ligand most probably via decarboxylation. This simple approach avoids potentially harmful metal-based oxidants and negates any issues associated with the disposal of their resultant (hazardous) waste. (C) 2010 Elsevier Ltd. All rights reserved.
• US9809586B2
  申请人：——

  公开号：US9809586B2

  公开（公告）日：2017-11-07
• [EN] INHIBITORS OF COLLAGEN PROLYL 4-HYDROXYLASE<br/>[FR] INHIBITEURS DE LA COLLAGÈNE PROLYL-4-HYDROXYLASE
  申请人：WISCONSIN ALUMNI RES FOUND

  公开号：WO2016160706A1

  公开（公告）日：2016-10-06

  Biheteroaryl dicarboxylates and esters, and salts thereof which are useful as modulators of CP4H activity and more particularly as inhibitors of CP4H. Compounds of formula (I) and salts thereof where: X is S, O, NH, or NR, where R is an alkyl group having 1-3 carbon atoms; R1 and R2 independently are -OR7, or -NHSO2R8, where R7 is selected from: hydrogen, alkyl, alkenyl, alkoxyalkyl, -R'-CO-R", -R'-CO-O-R", -CO-R", -R'-O-CO-R", -R'-CO-NR", -CO-NR", or -R'-O-CO-NR", and R8 is selected from hydrogen, alkyl, aryl, arylalkyl; R3, R4 and R6 independently are hydrogen, alkyl, alkoxy, alkenyl, alkenoxy, haloalkyl, haloalkenyl, halogen, hydroxyl, hydroxyalkyl, hydroxyalkenyl, aryl, aryloxy, arylalkyl or arylalkyloxy; R5 is hydrogen, halogen, alkyl having 1-3 carbon atoms, or alkoxy having 1-3 carbon atoms; -R'- is a divalent straight chain or branched alkylene, and-R" is an alkyl, alkenyl, arylalkyl, or aryl group. Methods for inhibition of CP4H in vivo and in vitro.
• INHIBITORS OF COLLAGEN PROLYL 4-HYDROXYLASE
  申请人：WISCONSIN ALUMNI RESEARCH FOUNDATION

  公开号：US20160280701A1

  公开（公告）日：2016-09-29

  Biheteroaryl dicarboxylates and esters, and salts thereof which are useful as modulators of CP4H activity and more particularly as inhibitors of CP4H. Compounds of formula: and salts thereof where: X is S, O, NH, or NR, where R is an alkyl group having 1-3 carbon atoms; R 1 and R 2 independently are —OR 7 , or —NHSO 2 R 8 , where R 7 is selected from: hydrogen, alkyl, alkenyl, alkoxyalkyl, —R′—CO—R″, —R′—CO—O—R″, —CO—R″, —R′—O—CO—R″, —R′—CO—NR″, —CO—NR″, or —R′—O—CO—NR″, and R 8 is selected from hydrogen, alkyl, aryl, arylalkyl; R 3 , R 4 and R 6 independently are hydrogen, alkyl, alkoxy, alkenyl, alkenoxy, halo alkyl, haloalkenyl, halogen, hydroxyl, hydroxyalkyl, hydroxyalkenyl, aryl, aryloxy, arylalkyl or arylalkyloxy; R 5 is hydrogen, halogen, alkyl having 1-3 carbon atoms, or alkoxy having 1-3 carbon atoms; —R′— is a divalent straight chain or branched alkylene, and —R″ is an alkyl, alkenyl, arylalkyl, or aryl group. Methods for inhibition of CP4H in vivo and in vitro.

  Biheteroaryl二羧酸酯和酯，以及它们的盐，可用作CP4H活性的调节剂，更具体地作为CP4H的抑制剂。化合物的结构式:及其盐，其中:X为S、O、NH或NR，其中R为具有1-3个碳原子的烷基基团；R1和R2独立地为—OR7，或—NHSO2R8，其中R7选自：氢、烷基、烯基、烷氧基烷基、—R′—CO—R″、—R′—CO—O—R″、—CO—R″、—R′—O—CO—R″、—R′—CO—NR″、—CO—NR″或—R′—O—CO—NR″，而R8选自氢、烷基、芳基、芳基烷基；R3、R4和R6独立地为氢、烷基、烷氧基、烯基、烯氧基、卤代烷基、卤代烯基、卤素、羟基、羟基烷基、羟基烯基、芳基、芳氧基、芳基烷基或芳基烷氧基；R5为氢、卤素、具有1-3个碳原子的烷基，或具有1-3个碳原子的烷氧基；—R′—为二价的直链或支链烷基，而—R″为烷基、烯基、芳基烷基或芳基。用于体内和体外抑制CP4H的方法。